CARVANA CO (CVNA)

US1468691027 - Common Stock

121.67  +5.17 (+4.44%)

After market: 122.2 +0.53 (+0.44%)

Fundamental Rating

4

CVNA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 126 industry peers in the Specialty Retail industry. The financial health of CVNA is average, but there are quite some concerns on its profitability. While showing a medium growth rate, CVNA is valued expensive at the moment.



3

1. Profitability

1.1 Basic Checks

In the past year CVNA has reported negative net income.
CVNA had a positive operating cash flow in the past year.
CVNA had negative earnings in 4 of the past 5 years.
In the past 5 years CVNA reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.36%, CVNA is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
With an excellent Return On Equity value of 185.19%, CVNA belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
Industry RankSector Rank
ROA 6.36%
ROE 185.19%
ROIC N/A
ROA(3y)-4.6%
ROA(5y)-5.01%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CVNA has a better Profit Margin (4.18%) than 72.22% of its industry peers.
With a Gross Margin value of 16.01%, CVNA is not doing good in the industry: 86.51% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CVNA has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 4.18%
GM 16.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.04%
GM growth 5Y9.7%

5

2. Health

2.1 Basic Checks

CVNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CVNA has more shares outstanding
The number of shares outstanding for CVNA has been increased compared to 5 years ago.
Compared to 1 year ago, CVNA has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.63 indicates that CVNA is not in any danger for bankruptcy at the moment.
CVNA has a better Altman-Z score (3.63) than 76.19% of its industry peers.
CVNA has a debt to FCF ratio of 8.76. This is a slightly negative value and a sign of low solvency as CVNA would need 8.76 years to pay back of all of its debts.
CVNA has a Debt to FCF ratio (8.76) which is comparable to the rest of the industry.
CVNA has a Debt/Equity ratio of 25.04. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CVNA (25.04) is worse than 84.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 25.04
Debt/FCF 8.76
Altman-Z 3.63
ROIC/WACCN/A
WACC9.28%

2.3 Liquidity

A Current Ratio of 2.16 indicates that CVNA has no problem at all paying its short term obligations.
CVNA has a Current ratio of 2.16. This is amongst the best in the industry. CVNA outperforms 83.33% of its industry peers.
CVNA has a Quick Ratio of 1.41. This is a normal value and indicates that CVNA is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.41, CVNA belongs to the best of the industry, outperforming 80.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.41

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.19% over the past year.
CVNA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.82%.
Measured over the past years, CVNA shows a very strong growth in Revenue. The Revenue has been growing by 40.68% on average per year.
EPS 1Y (TTM)53.19%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-356.41%
Revenue 1Y (TTM)-20.82%
Revenue growth 3Y24.46%
Revenue growth 5Y40.68%
Revenue growth Q2Q-14.56%

3.2 Future

The Earnings Per Share is expected to grow by 21.08% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 17.14% on average over the next years. This is quite good.
EPS Next Y10.15%
EPS Next 2Y13.5%
EPS Next 3Y17.77%
EPS Next 5Y21.08%
Revenue Next Year2.02%
Revenue Next 2Y8.27%
Revenue Next 3Y12.38%
Revenue Next 5Y17.14%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVNA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVNA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CVNA indicates a slightly more expensive valuation: CVNA is more expensive than 66.67% of the companies listed in the same industry.
CVNA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 34.35
EV/EBITDA 105.59

4.3 Compensation for Growth

CVNA's earnings are expected to grow with 17.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.5%
EPS Next 3Y17.77%

0

5. Dividend

5.1 Amount

CVNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CARVANA CO

NYSE:CVNA (5/3/2024, 7:04:00 PM)

After market: 122.2 +0.53 (+0.44%)

121.67

+5.17 (+4.44%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap24.60B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.36%
ROE 185.19%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 4.18%
GM 16.01%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 25.04
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.16
Quick Ratio 1.41
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)53.19%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y10.15%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-20.82%
Revenue growth 3Y24.46%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y